"We're a discovery company. We file intellectual property and we will not be in manufacturing, marketing or sales"

– Howard Urnovitz, CEO of Chronix, discussing his company's discoveries in DNA and RNA fragments, "Chronix breakthroughs to yield new 'routine' diagnostic tests," pp. 1, 8.